ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1377	National Cancer Institute	Html	en	Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for ovarian, fallopian tube, and primary peritoneal cancers.	ovarian cancer incidence 0.485939 PLCO trial participants 0.376238 annual CA-125 concentrations 0.379685 control group 0.373899 TVU 0.416096 intervention group 0.456353 ovarian cancer mortality 0.605058 usual-care group 0.519997 ovarian cancer. 0.438341 simultaneous screening 0.374743 multimodality screening 0.410213 ovarian cancer patients 0.493657 Ovarian Cancer Screening 0.521015 multimodality screening arm 0.400746 term ovarian cancer 0.514244 ovarian screening intervention 0.52207 Ovarian cancer diagnoses 0.474885 positive screening test 0.421138 ovarian cancer 0.995711 ovarian origin 0.452276 screening group 0.412155 PLCO trial 0.50373 screening centers 0.380449 Single-threshold CA-125 levels 0.385265	CA-125 reference value 0.384378 multimodal screening 0.42795 women 0.438262 screening test results 0.415787 low-grade serous carcinomas. 0.372717 ovarian cancers 0.495247 mortality rate ratio 0.417901 CA-125 concentrations 0.454756 screening protocol 0.374983 CA-125 levels 0.452675 incident ovarian cancers 0.460255 concurrent bulky carcinomas 0.374346 annual screening 0.391284 statistically nonsignificant mortality 0.377585 regular screening attendees 0.399753 ovarian volume increases 0.454792 high-grade serous carcinoma 0.426123 Shizuoka Cancer Registry 0.385833 epithelial ovarian carcinomas. 0.474733 cancer case treatment 0.383697 single-threshold CA-125 concentrations 0.37905 stage 0.375125 Elevated CA-125 levels 0.386511 Cancer Screening Trial 0.444611	CLICK HERE
1465	National Cancer Institute	Html	en	Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood acute myeloid leukemia, myelodysplastic syndromes, and other myeloproliferative disorders.	cytogenetically normal AML 0.472151 acute myelogenous leukemia 0.566998 acute myeloid leukemias 0.479592 acute leukemia cells 0.490369 Mixed-phenotype acute leukemia 0.492893 pediatric AML chromosomal 0.458451 acute leukemias 0.458907 mutations 0.522652 myeloid leukemia patients 0.500607 leukemia group 0.471134 biphenotypic acute leukemia 0.49298 children 0.465 pediatric myeloid leukemia 0.49349 childhood AML 0.456416 chronic myelomonocytic leukemia 0.469481 AML 0.543947 World Health Organization 0.492048 CEBPA mutations 0.477251 leukemia development 0.468848 acute monocytic leukemia 0.483805 chronic myelogenous leukemia 0.468404 Acute myelomonocytic leukemia 0.489711 prognostic significance 0.496134 international retrospective study 0.454979 promyelocytic leukemia cases 0.462082	pediatric leukemia 0.454781 pediatric AML patients 0.456596 et al. 0.655126 acute megakaryoblastic leukemia 0.509773 normal pediatric AML 0.45551 myeloid neoplasms 0.47963 internal tandem duplication 0.460861 Br J Haematol 0.501425 acute promyelocytic leukaemia 0.457345 normal myeloid development 0.457734 acute myeloid leukemia 0.996934 acute myeloid leukaemia 0.513022 Leukemia Study Group 0.464981 juvenile myelomonocytic leukemia 0.495899 myeloid leukemia cells 0.495298 acute megakaryocytic leukemia 0.484055 mixed lineage leukemia 0.460628 Abstract 0.599778 Clin Oncol 0.480965 AML patients 0.464901 blood 0.501248 promyelocytic leukemia correlates 0.463064 acute promyelocytic leukemia 0.625964 pediatric AML 0.496596	CLICK HERE
1679	National Cancer Institute	Html	en	Communication in Cancer Care (PDQ®)–Patient Version	It is important to talk to your doctor about your cancer diagnosis, goals of treatment, plan of care, and what to expect over time. Learn how good communication between patients, families, caregivers and doctors can improve the patient's quality of life in this expert-reviewed summary.	cancer treatment 0.389842 bad news 0.386292 questions 0.399361 PDQ cancer information 0.624305 health care team 0.981737 clinical trials 0.514782 Pediatric Supportive Care 0.404638 communication 0.486074 cancer information summary 0.515585 clinical trial 0.495706 family members 0.426143 cancer care 0.778281 breast cancer prevention 0.399685 PDQ summaries 0.394467 patients 0.573309 cancer patients 0.414288 team share information 0.427277 latest published information 0.403211 NCI’s PDQ 0.394236 PDQ summary Family 0.458483 NCI PDQ cancer 0.456705 supportive care 0.443184 treatment 0.599848 family caregivers 0.667411	cancer prevention 0.402033 Cancer Information Service 0.427003 Explain medical information 0.409499 PDQ Supportive 0.391221 patient 0.679815 PDQ Communication 0.403164 treatment clinical trials 0.401111 National Cancer Institute 0.597923 decisions 0.454448 PDQ documents 0.390179 Palliative Care Editorial 0.462952 medical information 0.462988 new treatment 0.398754 good communication 0.425774 Cancer Care page 0.429643 PDQ database 0.392979 Care Editorial Board 0.465833 PDQ summary 0.483184 doctor 0.450453 cancer clinical trials 0.415988 cancer information summaries 0.432334 comprehensive cancer information 0.43347 cancer patient 0.392432 cancer 0.840307	CLICK HERE
1816	National Cancer Institute	Html	es	Tratamiento del glioma de tronco encefálico infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del glioma de tronco encefálico infantil.	gliomas highlights platelet-derived 0.0180248 encefálico infantiles recién 0.0174306 focal brainstem gliomas 0.0175295 brainstem tumors 0.0356739 mutación h3 k27m 0.0183362 activating acvr1 mutations 0.0269847 pediatric brain 0.0219051 glioma with 0.0184685 encefálico focales recidivantes 0.0176848 Radiat Oncol Biol 0.0940294 Pediatric Brain Tumor 0.0189297 mutación h3 0.0289221 diffuse brainstem glioma 0.0359565 brainstem gliomas 0.119063 central nervous system 0.0139993 recurrent activating acvr1 0.0274852 Nat Genet 0.0675122 intrinsic brain stem 0.0150908 patients with 0.025125 radiation therapy 0.0349088 intrinsic pontine glioma 0.946885 Acta Neuropathol 0.0426011 encefálico infantiles grupo 0.0167365 Broniscer A 0.0151338 intrinsic brainstem gliomas 0.0346829	Pediatric MATCH 0.0156687 encefálico focales recién 0.0279293 Neuro Oncol 0.0299682 with newly 0.0211799 brain stem gliomas 0.0552126 encefálico infantiles recidivantes 0.0293915 pediatric patients 0.0205505 low-grade glioma 0.0256326 Pediatr Blood Cancer 0.019874 intracranial low-grade gliomas 0.0165924 report from 0.0151672 tumores dipg 0.0243332 encefálico focales resección 0.0182395 Clin Oncol 0.0362551 Oncol Biol Phys 0.0989347 Zhou T 0.0230102 Neurosurg Pediatr 0.0180743 Pediatric Oncology Group 0.0173483 newly diagnosed 0.0303637 with neurofibromatosis 0.0165895 children's oncology group 0.138637 Acta Neuropathol Commun 0.0194776 Childs Nerv Syst 0.0434615 diffuse intrinsic pontine 0.990784	CLICK HERE
1921	National Cancer Institute	Html	es	Tratamiento del cáncer de piel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de piel.	almacena agua 0.377251 siguientes procedimientos 0.484494 Estadio IA 0.400496 estadio iv 0.835623 Estadio IC 0.400325 siguientes aspectos 0.39369 estadio ii 0.685519 Estadio IIIC 0.402008 estadios ia 0.349569 Estadio IIIA 0.403211 rayos x 0.363326 pulmón.ampliar cáncer 0.632928 menor cantidad 0.423989 luz solar 0.966967 Basal Cell Carcinoma 0.789488 vitamina d 0.373991 National Cancer Institute 0.332744	vitamina a 0.337818 siguientes riesgos 0.326866 pequeños carcinomas 0.336448 Instituto Nacional 0.361575 PDQ Tratamiento 0.358407 Drugs Approved 0.513635 Physician Data Query 0.424982 Cabello pelirrojo 0.519578 lápiz mide 0.408824 siguientes características 0.456672 cara.ampliar cirugía 0.345299 aspecto anormal.ampliar biopsia 0.448697 piel causa efectos 0.518422 panel derecho 0.432885 siguientes sumarios 0.432177 siguientes pruebas 0.387403	CLICK HERE
2075	National Cancer Institute	Html	es	Cánceres de cabeza y cuello	Hoja informativa acerca de los factores de riesgo, síntomas, diagnóstico, tratamiento, seguimiento y rehabilitación por los cánceres de cabeza y cuello.	Neck Cancer Epidemiology 0.358567 3rd ed 0.326841 NCI Vacunas 0.308043 American Cancer Society 0.337456 Epstein-Barr virus with 0.308914 Epstein-Barr virus 0.318034 Cancer Statistics 0.318768 Winn DM 0.308575 escamoso metastático 0.312489 case-control studies 0.308924 Cancer Institute State 0.321996 risk factors 0.312336 Brennan P 0.309874 Estados Unidos 0.32769 PubMed Abstract 0.972002 Gillison ML 0.308728 neck cancers 0.463711 Leclerc A 0.308319 patients with 0.31588 Cancer Epidemiology 0.478301 epstein-barr virus dna 0.30801 Boffetta P 0.327923 Chuang SC 0.308139 Cancer Epidemiology Consortium 0.352034 Cancer Journal 0.322016	International Journal 0.329442 Schottenfeld D 0.32536 upper aerodigestive tract 0.317554 second primary tumors 0.315336 United States 0.307873 neck squamous 0.307836 Fraumeni JF Jr 0.348613 International Head 0.313722 Nasopharyngeal Cancer 0.321339 occupational exposure 0.308922 National Cancer Institute 0.392376 Cancer Research 0.332513 Oxford University 0.322621 New York 0.321319 Yuan JM 0.308767 Epstein-Barr virus infection 0.308137 nasopharyngeal carcinoma 0.309899 international case-control study 0.316625 cáncer del nci 0.316951 Neck Surgery 0.30769 pooled analysis 0.329801 Clinical Cancer Research 0.320259 Habitual risk factors 0.308377 Cancer Biology 0.320747	CLICK HERE
3451	National Cancer Institute	Html	en	Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ®)–Patient Version	Expert-reviewed information summary about the preparation needed by health care providers, patients, and families for the transition to end-of-life care in advanced cancer.	CPR 0.551685 end-of-life decisions 0.505947 treatments 0.539675 PDQ cancer information 0.625539 Out-of-hospital DNR order 0.511763 health care team 0.497649 clinical trials 0.511926 wishes 0.516111 health care providers 0.549541 emergency medical workers 0.548212 cancer information summary 0.569329 health care professionals 0.505787 family members 0.526957 patients 0.489953 end-of-life care options 0.519094 symptoms 0.496271 NCI PDQ cancer 0.514682 new chemotherapy treatment 0.48923 doctors 0.602249 supportive care 0.525701 life-saving procedures 0.497748 care 0.924816 end-of-life care 0.782032 treatment 0.671878	DNR order 0.576468 Palliative Care Organization 0.500652 breathing stops 0.496404 palliative care 0.693314 Cancer Information Service 0.494158 Health care proxy 0.49362 cardiopulmonary resuscitation 0.54384 hospice care 0.526131 National Cancer Institute 0.571506 decisions 0.647069 Advance directives 0.611485 health care 0.652677 Palliative Care Editorial 0.541845 advanced cancer 0.542943 Cancer Care page 0.510244 Care Editorial Board 0.540113 PDQ summary 0.57393 doctor 0.567646 end stages 0.495403 breathing machine 0.491509 cancer information summaries 0.492454 comprehensive cancer information 0.492895 cancer 0.776389 information 0.649786	CLICK HERE
3526	National Cancer Institute	Html	es	Dosis altas de vitamina C (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de dosis altas de vitamina C como tratamiento para personas con cáncer.	cuerpo capta 0.40884 Centro Nacional 0.415435 trastornos renales 0.409265 New Hampshire Avenue 0.4108 voluntarios sanos 0.40968 Drug Administration 0.406678 NCI Best Case 0.417317 vía oral 0.410816 datos bibliográficos pubmed 0.411428 Ewan Cameron 0.409689 siguientes preguntas 0.406272 modelo murino 0.409716 PDQ Dosis 0.435611 químico linus pauling 0.417313 vitamina c 0.94266 National Cancer Institute 0.412764 siguientes riesgos 0.407804 Instituto Nacional 0.459849 quimio terapia 0.40979	premio nobel 0.409373 Salud Complementaria 0.42125 medicamento bortezomib 0.415099 Visuals Online 0.407849 complementarias revisa 0.410331 pequeñas cantidades 0.408757 Physician Data Query 0.445061 Estados Unidos 0.504589 cálculos renales 0.409375 libre uso 0.407317 cabo estudios 0.435571 claro cuánto 0.409653 página manejo 0.407381 ¿El tratamiento 0.414934 ¿Los beneficios 0.406643 juntos cam 0.406416 Series Program 0.406643 medicina complementaria 0.607291	CLICK HERE
3606	National Cancer Institute	Html	en	Bioinformatics and Cancer	Researchers take on challenges and opportunities to mine	analytical tools 0.503896 data 0.930485 complex biological questions 0.5412 computational tools 0.425959 research 0.765612 research program 0.461031 precision medicine—that 0.427901 Cancer Informatics Program 0.53792 primary data 0.493101 research community 0.640856 comprehensive molecular analyses 0.497733 cancer research data 0.639487 researchers 0.498144 molecular characteristics 0.432662 Big Data 0.513141 NCI’s Center 0.486223 NCI-funded studies 0.438225 NCIP Hub 0.491716 commercial cloud providers 0.498944 cloud technology 0.483618 Genome Research Institute 0.551547 cancer research community 0.589113 access 0.431106 numerous research areas 0.554113 imaging studies 0.432684	NCI-funded research 0.466881 cancer research 0.762444 healthy tissue samples 0.490086 data clouds 0.491108 NCI’s TARGET 0.476821 TCGA-collected data 0.483444 Genomic Data Sharing 0.579305 molecular data 0.478795 multi-investigator research teams 0.550054 different technological platforms 0.513272 studies 0.49641 translational studies 0.42911 sheer volume 0.427853 NCI Cancer Genomics 0.60107 cancer researchers 0.462047 cancer genomics repository 0.530232 biological data 0.643746 clinical care 0.431785 different tools 0.428018 Cancer Genome Atlas 0.527253 biomedical research 0.47962 cancer research projects 0.699979 potential new targets 0.495536 NCI Genomic Data 0.63374	CLICK HERE
15642	National Cancer Institute	Html	en	Introduction to the Grants Process	Information about the NCI grants process, including recipient eligibility, the different people involved, and information about funding.	Grant section 0.330468 Grants Management Officer 0.557994 business management aspects 0.330645 Revision /Administrative Supplement 0.292103 ongoing extramural activity 0.334159 individual collaborates 0.230568 visit nci 0.417726 legally binding document 0.294148 grant type 0.376998 Application Development 0.390783 funding opportunity announcements 0.296925 particular grant program 0.476454 Research grant funds 0.454642 federal financial assistance 0.312865 scientific research projects 0.381722 additional history 0.228572 Name-Change Agreements 0.225495 cooperative agreement 0.324362 Federal funding limits 0.287544 cancer research services 0.337764 scientific aims 0.238931 recipient organizations 0.237533 NIH organizational component 0.335362 cooperative agreements 0.410646	scientific responsibility 0.224818 basic information 0.22908 Program Announcement 0.22809 clinical research 0.242867 grant application submissions 0.45483 Institutional Business Official 0.318274 grant award 0.34942 important process 0.252274 extramural scientists/clinicians 0.245811 grant application types 0.455543 recipient organization officials 0.350637 NCI Program Directors/Program 0.52301 Grants Management Specialists 0.412374 NCI Grants Management 0.594717 NCI grants process 0.906594 Program Announcements 0.289703 research organization 0.254758 Grants.gov Authorized Organizational 0.310309 cancer care delivery 0.312355 grant portfolio 0.3628 NCI grants program 0.607154 extramural program 0.270142 application process 0.236143 Recipient Institution/Organization 0.256421	CLICK HERE